M. Peart

发表

Anticancer activities of histone deacetylase inhibitors

Jessica E. Bolden, J. Bolden, R. Johnstone, 2006, Nature Reviews Drug Discovery.

Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.

J. Trapani, R. Johnstone, L. O'Reilly, 2003, Cancer research.

G2/M checkpoint gene expression in developing germ cells

M. Tymms, J. Hutson, M. Peart, 2007, Molecular reproduction and development.

Epigenetic Drugs : Histone Deacetylase Inhibitors

R. Johnstone, M. Peart, 2008 .

Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors.

R. Johnstone, A. Wiegmans, L. Cluse, 2009, Blood.

A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

C. Prives, A. J. Donner, J. Espinosa, 2009, Genes & Development.

Stxbp4 Regulates ΔNp63 Stability by Suppression of RACK1-Dependent Degradation

C. Prives, M. Peart, Yingchun Li, 2009, Molecular and Cellular Biology.

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.

Gordon K Smyth, Andrew J Holloway, Ricky W Johnstone, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Mutant p53 gain of function: the NF-Y connection.

C. Prives, M. Peart, 2006, Cancer Cell.

Lysine-Independent Turnover of Cyclin G1 Can Be Stabilized by B′α Subunits of Protein Phosphatase 2A

C. Prives, Hongyun Li, K. Okamoto, 2008, Molecular and Cellular Biology.

APC/CCdc20 targets E2F1 for degradation in prometaphase

Carol Prives, Emmy W Verschuren, E. Kass, 2010, Cell cycle.

A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

C. Prives, A. J. Donner, J. Espinosa, 2009, Genes & development.

Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors.

R. Johnstone, A. Wiegmans, L. Cluse, 2009, Blood.